Paper393288
Treatment of severe hypertension by repeated bolus injections of labetalol.
Cumming AM and 4 others. Br J Clin Pharmacol, 1979. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Treatment of severe hypertension by repeated bolus injections of labetalol. Papers, record 393288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/393288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ethanolamines | Major topic |
| Hypertension | Major topic |
| Labetalol | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Angiotensin II | |
| Blood Pressure | |
| Creatinine | |
| Female | |
| Humans | |
| Hypertension, Malignant | |
| Injections, Intravenous | |
| Male | |
| Middle Aged | |
| Renin |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13849070 | The electrocardiogram in population studies. A classification system. | Circulation | 1960 | https://conductscience.org/library/papers/13849070 | PubMed |
| 2 | 667883 | Management of complicated hypertension including hypertensive emergencies. | Cardiovasc Clin | 1978 | https://conductscience.org/library/papers/667883 | PubMed |
| 3 | 68239 | Labetalol in hypertension. | Lancet | 1977 | https://conductscience.org/library/papers/68239 | PubMed |
| 4 | 25757 | Labetalol: a review of its pharmacology and therapeutic use in hypertension. | Drugs | 1978 | https://conductscience.org/library/papers/25757 | PubMed |
| 5 | 4692673 | Autoregulation of brain circulation in severe arterial hypertension. | Br Med J | 1973 | https://conductscience.org/library/papers/4692673 | PubMed |
| 6 | 990152 | Metabolism of labetalol by animals and man. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/990152 | PubMed |
| 7 | 4333501 | Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. | Eur J Clin Invest | 1971 | https://conductscience.org/library/papers/4333501 | PubMed |
| 8 | 4425852 | Ischaemic heart disease in young women. | Br Med J | 1974 | https://conductscience.org/library/papers/4425852 | PubMed |
| 9 | 791333 | Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/791333 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7093106 | Intravenous labetalol in severe hypertension. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093106 | PubMed |
| 6653648 | Diazoxide and labetalol in acute hypertension during haemodialysis. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6653648 | PubMed |
| 6151891 | Combined alpha- and beta-receptor inhibition in the treatment of hypertension. | Drugs | 1984 | https://conductscience.org/library/papers/6151891 | PubMed |
| 6151890 | Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol. | Drugs | 1984 | https://conductscience.org/library/papers/6151890 | PubMed |
| 6147240 | Hypertension in pregnancy. Pathophysiology and management. | Drugs | 1984 | https://conductscience.org/library/papers/6147240 | PubMed |
| 6124265 | Comparison of labetalol with other anti-hypertensive drugs. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6124265 | PubMed |
| 3123620 | Hypertensive emergencies and urgencies: definition, recognition, and management. | J Gen Intern Med | 1988 | https://conductscience.org/library/papers/3123620 | PubMed |
| 2770185 | [Effectiveness and hemodynamic mechanism of action of blood pressure lowering by intravenous labetalol in patients with a critical increase in blood pressure]. | Klin Wochenschr | 1989 | https://conductscience.org/library/papers/2770185 | PubMed |
| 526408 | Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/526408 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/393288
GET https://conductscience.org/api/papers/v1/393288/authors